Athos Therapeutics, Inc. — Form D

Athos Therapeutics, Inc. of TORRANCE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-15. The offering totals $20.0M, of which $10.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2026-05-15
• Form: D
• Accession: 0001885079-26-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $20.0M
• Amount sold: $10.3M
• Remaining: $9.7M
• Investors: 40
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-584143

Issuer

• Name: Athos Therapeutics, Inc.
• CIK: 0001885079
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 1123 W. CARSON ST., TORRANCE, CA, 90502
• Phone: 857-222-0410

Officers, directors & promoters (13)

Other filings by this issuer (3)

More

• CIK 1885079 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search